Transatlantique Private Wealth LLC grew its stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 170.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,702 shares of the company’s stock after purchasing an additional 2,964 shares during the period. Transatlantique Private Wealth LLC’s holdings in Astera Labs were worth $782,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Goldstein Advisors LLC raised its position in Astera Labs by 5.8% in the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares during the last quarter. CIBC Asset Management Inc raised its position in Astera Labs by 41.0% during the 4th quarter. CIBC Asset Management Inc now owns 6,838 shares of the company’s stock worth $1,138,000 after buying an additional 1,988 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Astera Labs by 189.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after purchasing an additional 858,693 shares in the last quarter. Main Management ETF Advisors LLC increased its holdings in shares of Astera Labs by 1.0% in the 4th quarter. Main Management ETF Advisors LLC now owns 18,792 shares of the company’s stock valued at $3,126,000 after purchasing an additional 192 shares in the last quarter. Finally, Hazlett Burt & Watson Inc. increased its holdings in shares of Astera Labs by 29.7% in the 4th quarter. Hazlett Burt & Watson Inc. now owns 4,244 shares of the company’s stock valued at $707,000 after purchasing an additional 971 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.
Insider Activity
In other news, COO Sanjay Gajendra sold 400,000 shares of the business’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at approximately $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the business’s stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the transaction, the chief executive officer directly owned 4,079,322 shares of the company’s stock, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 2,298,757 shares of company stock valued at $472,787,436. 10.40% of the stock is currently owned by company insiders.
Astera Labs Trading Up 2.2%
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s revenue was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of brokerages recently commented on ALAB. Jefferies Financial Group reissued a “buy” rating and issued a $270.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price on the stock. Barclays raised their target price on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Royal Bank Of Canada raised their price target on shares of Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, May 6th. Finally, Citigroup lowered shares of Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $233.75.
Read Our Latest Stock Analysis on ALAB
Astera Labs Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- As AI Data Breaches Become More Common, This Cybersecurity ETF Is SurgingAI
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
